From Exclusion to Inflammation: Stress, Cortisol, and the Gut

1. Social Stress and Activation of the Stress Axis

Evidence-based: Chronic social stress—such as exclusion or isolation—demonstrably increases cortisol release and activates the HPA axis.

Plausible The CTRA involves upregulation of pro-inflammatory genes (e.g., IL-1β, IL-6) and suppression of antiviral genes. Animal models confirm that social stress affects the blood-brain barrier and triggers neuroinflammatory processes.

Hypothesis If social stress activates the CTRA, this could act as a central switch for the subsequent inflammatory cascade. It would need to be tested whether targeted psychosocial interventions (e.g., mindfulness training) can sustainably modulate CTRA gene expression in high-risk groups (e.g., long-term unemployed individuals).

Substances involved at this stage: Stress, cortisol and inflammation

2. Chronically Elevated Cortisol and Glucocorticoid Resistance

Evidence-based: Chronically elevated cortisol levels—measured in saliva, hair, or plasma—correlate with HPA axis dysregulation and glucocorticoid resistance. Studies show that cortisol under stress correlates positively with IL-10 and IFNα but negatively with MCP-1 2.

Plausible Glucocorticoid resistance arises from reduced expression of the glucocorticoid receptor (NR3C1), as demonstrated in patients with early childhood trauma 3. This leads to a paradoxical pro-inflammatory tendency, as cortisol loses its immunosuppressive effect. Animal studies show that chronic stress increases intestinal permeability—a potential link to subsequent microbiome dysbiosis.

Hypothesis Glucocorticoid resistance could be a key mechanism sustaining low-grade inflammation despite high cortisol levels. Humic acid complexes or omega-3 fatty acids might intervene here by stabilising NR3C1 expression or restoring immune cells’ cortisol sensitivity.

3. Low-Grade Inflammation: IL-6, CRP, TNF-α, and CTRA

Evidence-based: Chronic stress induces low-grade inflammation, measurable by elevated markers such as IL-6, CRP, and TNF-α. In breast cancer patients, CTRA gene expression correlates with shorter disease-free survival 4. Endotoxin studies show that socially isolated participants exhibit an amplified pro-inflammatory response (TNF-α, IL-6) 5.

Plausible The CTRA is an evolutionarily conserved mechanism originally serving infection defence. Under chronic stress, however, it becomes maladaptive and promotes systemic inflammation. Reviews indicate that IL-6 and CRP are not merely markers but active drivers of diseases such as diabetes or depression 6.

Hypothesis Low-grade inflammation could feed back onto the microbiome via the gut barrier: inflammatory mediators like TNF-α increase intestinal permeability, which in turn perpetuates inflammation. Humic acid complexes might act as inflammation modulators by binding cytokines such as IL-6 or TNF-α and disrupting their signalling pathways.

Substances involved at this stage: Stress, cortisol and inflammation · Chronic inflammation

4. Intestinal Barrier and Permeability Under Stress

Evidence-based: Chronic stress increases intestinal permeability (leaky gut), measurable by elevated zonulin or LPS levels in the blood.

Plausible Stress activates the HPA axis and elevates cortisol, which downregulates the expression of tight junction proteins (e.g., occludin, claudin). Animal studies demonstrate that cortisol directly damages the gut barrier and promotes LPS translocation. This triggers local and systemic inflammation, further weakening barrier function.

Hypothesis The compromised gut barrier could be a central amplifier of the stress-inflammation spiral. Humic acid complexes might act as a physical barrier by binding LPS and stabilising tight junctions. It would need to be tested whether they reduce zonulin release.

Substances involved at this stage: Stress, cortisol and inflammation · Gut microbiome · Humic acid complexes · Mineral binders (zeolite, bentonite)

5. Microbiome and Butyrate as Counter-Regulators

Evidence-based: Chronic stress alters the composition of the microbiome. Studies show that butyrate supplementation prolongs remission in colitis 7.

Plausible Butyrate exerts multiple effects: it promotes the expression of tight junction proteins, inhibits NF-κB (a central inflammatory mediator), and induces regulatory T cells. Animal studies demonstrate that butyrate enhances stress resilience by modulating the HPA axis. Probiotics such as Akkermansia muciniphila improve barrier function and reduce LPS translocation 8.

Hypothesis Butyrate may be a central mediator that interrupts the stress-inflammation cascade. Humic acid complexes could promote butyrate production by providing prebiotic substrates for the microbiota. It would need to be investigated whether they act synergistically with butyrate-producing bacteria.

Substances involved at this link: Butyrate (butyric acid) · Gut microbiome · Probiotics · Beta-glucans

6. Points of Intervention: Binding, Barrier, Inflammation Regulation

Evidence-based: Natural compounds target various links in the cascade: Curcumin reduces IL-6, TNF-α, and CRP in metabolic syndrome 9 and improves endothelial function 11. Omega-3 fatty acids lower triglycerides and inflammatory markers (e.g., IL-1β) 10. Probiotics such as Lactobacillus plantarum reduce stress and cortisol 1.

Plausible Humic acid complexes bind LPS and cytokines (e.g., TNF-α) and may thus interrupt the inflammatory cascade. In vitro, they demonstrate antioxidant and immunomodulatory effects. Animal studies suggest they stabilise the gut barrier and increase microbiome diversity. Curcumin and omega-3 also act on the HPA axis by restoring cortisol sensitivity.

Hypothesis A combination of humic acid complexes (barrier, LPS binding), butyrate (microbiome, immunomodulation), and curcumin (anti-inflammatory effects) could interrupt the stress-inflammation cascade at multiple points. It would need to be investigated whether these substances act synergistically and whether they sustainably modulate CTRA gene expression in chronic stress.

Substances involved at this link: Humic acid complexes · Mineral binders (zeolite, bentonite) · Omega-3 fatty acids · Turmeric and curcumin · Frankincense (Boswellia) · Adaptogens

Implications and Further Research Required

The following questions would need to be addressed in a controlled study: 1. Causal chain: Does chronic stress first lead to glucocorticoid resistance and then to low-grade inflammation — or do both processes occur in parallel? 2. Natural compounds: Do humic acid complexes act primarily via LPS binding or additionally through modulation of CTRA gene expression? 3. Synergies: Do humic acid complexes, butyrate, and curcumin enhance each other’s effects on the gut barrier and inflammation? 4. Long-term effects: Can these substances sustainably improve stress resilience — for example, by normalising the HPA axis? 5. Target groups: In which patient groups (e.g., metabolic syndrome, depression, or autoimmune diseases) is the effect most pronounced? Methodologically, the study would need to longitudinally assess cortisol (hair/saliva), inflammatory markers (IL-6, CRP, TNF-α), gut permeability (zonulin, LPS), and microbiome composition (16S rRNA sequencing).

Further cascades: All context pages · Interaction network · Gaps list